Transfusion science · NHS Bands 2–8

Blood transfusion interview questions and training for NHS biomedical scientists

Virtual blood bank, advanced LIMS validation, major-haemorrhage protocol training, Kleihauer-Betke workflow, antibody-panel interpretation and serology reference, built around MHRA, JPAC and SaBTO standards.

Reviewed by Desmond O., HCPC-registered Biomedical Scientist, and the PathologyLabTraining editorial team

MHRA / JPAC
Major haemorrhage protocol
LIMS validation
Bench simulation

Virtual transfusion science laboratory

Comprehensive interactive blood bank laboratory with realistic workflows, emergency scenarios and progressive training modules, for graduates through advanced practitioners.

Virtual Transfusion Science Laboratory Suite is available to premium subscribers and trial users.

LIMS

Advanced transfusion LIMS

Laboratory information management for transfusion validation, blood product management and cross-department result analysis.

Transfusion LIMS System is available to premium subscribers and trial users.

Critical care

Major haemorrhage protocol training

Practise life-critical protocols in an immersive simulation environment: the scenarios every transfusion BMS must defend in panel and at coroner inquest.

Major Haemorrhage Protocol

Code Red Simulation Training

NEW

Immersive simulation for UK Blood Transfusion Scientists handling life-threatening haemorrhage emergencies. Practice MHP activation, component selection, and clinical decision-making under time pressure.

12 Scenarios

15-20 mins

BSH Based

Obstetric
Trauma
Surgical
Neonatal
Haem/Onc
Special

Key Learning: MHP activation, O D negative stewardship, component choice without a fixed ratio, fibrinogen replacement, SBAR communication, and clinical decision-making reflecting BSH and NICE guidelines.

Foetomaternal haemorrhage

Kleihauer testing

Kleihauer-Betke assay workflow and FMH quantification for anti-D dosing decisions.

Kleihauer Blood Film Examination

Learn how to interpret Kleihauer-Betke test results, calculate fetomaternal haemorrhage volume, and determine appropriate anti-D immunoglobulin dosing according to UK guidelines

Kleihauer-Betke Test Examination & Interpretation

Laboratory professionals examine Kleihauer-Betke tests microscopically to detect fetal haemoglobin in maternal blood. Adult haemoglobin is eluted and the cells appear as "ghosts", while fetal haemoglobin resists acid elution and stains pink/red. Use the virtual microscope to examine each sample in detail.

Negative

0% fetal cells

Negative acid elution field: every red cell is a pale adult ghost and no pink fetal cells are seen.

Positive: about 11 mL FMH

0.5% fetal cells

Positive acid elution field with about 0.5% fetal cells (pink) among adult ghost cells, equivalent to about 11 mL of fetal red cells (0.5 × 18 × 1.22). This exceeds the 4 mL covered by a 500 IU standard dose.

Positive: about 44 mL FMH

2% fetal cells

Positive acid elution field with about 2% fetal cells (pink) among adult ghost cells, equivalent to about 44 mL of fetal red cells.

Positive: about 110 mL FMH

5% fetal cells

Positive acid elution field with about 5% fetal cells (pink) among adult ghost cells, equivalent to about 110 mL of fetal red cells. A bleed of this size needs flow cytometry confirmation and urgent clinical and specialist advice.

Laboratory Examination Procedure

In laboratory practice, Kleihauer-Betke (KB) tests are examined using brightfield microscopy. The microscopist:

  1. Prepares a maternal blood smear and treats it with acid buffer (pH 1.5-2.0)
  2. Stains the slide so that fetal cells stain pink/red and adult cells remain as pale ghosts
  3. Screens at least 25 low power fields (x10 eyepiece, x10 objective) for fetal cells
  4. Counts both adult cells (appear as "ghosts") and fetal cells (stained pink/red)
  5. If quantification is needed, counts fetal cells against at least 10,000 maternal ghosts using a x40 objective and an eyepiece grid (Miller square)
  6. Reports the estimated FMH in mL of fetal red cells, with advice on any additional anti-D and follow-up

Interpretation Guide

Less than 2 mL fetal red cells

Covered by the standard anti-D dose. The report says the FMH is less than 2 mL rather than "negative", so the standard dose is still given.

2 mL or more

Confirm by flow cytometry on the original sample. Phone a preliminary result to the ward so additional anti-D can be given within 72 hours.

4 mL or more

A significant FMH. A 500 IU dose covers up to 4 mL, so give additional anti-D at 125 IU per mL of fetal red cells (IM) and take a follow-up sample to check clearance.

Follow-up sample

Taken 72 hours after intramuscular anti-D (48 hours if given intravenously). Repeat anti-D and testing until fetal cells have cleared.

The virtual microscope simulation replicates the examination process used in clinical laboratories, allowing for practice in identifying and differentiating adult and fetal cells.

Blood group serology

Blood group serological reactions

Professional guide to serological reactions of different blood groups, their identification, and compatibility for transfusions.

In serological testing, "+" indicates agglutination (positive reaction) and "−" indicates no agglutination (negative reaction). These reactions help identify blood group antigens and antibodies.

Blood GroupAnti-AAnti-BAnti-DInterpretation
A++−+A antigen present, B antigen absent, Rh(D) antigen present
A-+−−A antigen present, B antigen absent, Rh(D) antigen absent
B+−++B antigen present, A antigen absent, Rh(D) antigen present
B-−+−B antigen present, A antigen absent, Rh(D) antigen absent
AB++++Both A and B antigens present, Rh(D) antigen present
AB-++−Both A and B antigens present, Rh(D) antigen absent
O+−−+Neither A nor B antigen present, Rh(D) antigen present
O-−−−Neither A nor B antigen present, Rh(D) antigen absent
Compatibility

Antibody panel interpretation

Interpret antibody panels through practical examples: IgG and enzyme reactions and complex cases requiring referral to the reference laboratory.

Antibody Panel Interpretation

Interactive examples of common antibody panels with interpretation guidelines

Anti-D Antibody Example

Common antibody in the Rhesus system

Patient Details

ABO Group: O
Rhesus: Negative
Auto Control: Negative
DAT: Negative
History: Female patient, 32 years old, second pregnancy

Interpretation Summary

Positive reactions with D-positive cells only

Conclusion

Anti-D antibody identified

CellRT (IS)IAT 37°CEnzyme
1NEG3+POS
2NEG3+POS
3NEGNEGNEG
4NEG4+POS
5NEGNEGNEG
6NEG3+POS
7NEGNEGNEG
8NEG3+POS
9NEG2+POS
10NEGNEGNEG
11NEG3+POS

Reaction Key

Understanding blood transfusion reaction strengths

4+Strong agglutination, clear background
3+Strong agglutination, turbid background
2+Medium sized agglutinates, turbid background
1+Small agglutinates, turbid background
w+Very small agglutinates, visible with magnification
NEGNo agglutination, homogeneous suspension

Testing Methods:

RT: Room Temperature (Immediate Spin)

IAT 37°C: Indirect antiglobulin test (anti-human globulin), the phase that detects IgG alloantibodies

Enzyme: Enhanced testing with enzymes

Learning Resources

Recommended resources for antibody identification

JPAC Red Book

Guidelines for the Blood Transfusion Services in the UK, chapter 13: patient testing and red cell immunohaematology

British Society for Haematology (BSH)

Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories (2013)

Serious Hazards of Transfusion (SHOT)

UK haemovigilance annual reports and case lessons on antibody-related incidents

Key Concepts:

Pattern recognition in antibody panels
Resolving multiple antibodies
Clinical significance of antibodies
Surveillance data

Transfusion science data visualisation

Interactive charts and graphs showcasing key transfusion science metrics, major haemorrhage protocols and their clinical significance.

Blood Group Distribution

Approximate distribution of ABO and Rhesus blood groups in the UK population

Approximate UK blood group distribution: O+ 37%, A+ 35%, B+ 8%, AB+ 3%, O- 7%, A- 7%, B- 2%, AB- 1%.

Clinical Significance:

  • O negative is the universal donor for red cells
  • AB positive is the universal recipient for red cells
  • Donor recruitment strategies target rarer blood types
  • Blood group distribution varies by ethnicity and geographic region
Foundations

Transfusion science quick guide

Essential knowledge areas for transfusion science, from foundational concepts to specialised techniques.

Blood Group Systems

ABO, Rhesus and other blood group systems, including antibody identification and compatibility testing.

Component Preparation

Processing, preparation, storage and quality control of different blood components.

Clinical Applications

Indications for transfusion, major haemorrhage protocols, and patient blood management.

Adverse Reactions

Types of transfusion reactions, investigation protocols, and preventive measures.

Transfusion Safety

Haemovigilance, traceability, SHOT reporting, and error reduction strategies.

Regulations & Guidelines

BSH transfusion guidelines, the JPAC Red Book, MHRA requirements, quality management systems and UKAS accreditation standards.

Sources and guidance

This hub's content aligns with the UK's professional and regulatory references for the specialty: